Today: 20 May 2026

Coinbase stock drops after-hours on surprise loss; COIN traders brace for Friday test

Coinbase stock drops after-hours on surprise loss; COIN traders brace for Friday test

Coinbase shares fell 7.9% to $141.09 in after-hours trading Thursday after posting a surprise quarterly net loss of $666.7 million, or $2.49 per share, missing analyst forecasts. Transaction revenue dropped to $982.7 million as trading slowed. Subscription and services revenue reached $727.4 million, with the company forecasting a softer outlook for the current quarter.
Rivian stock jumps after hours as $45,000 R2 fuels 2026 delivery forecast

Rivian stock jumps after hours as $45,000 R2 fuels 2026 delivery forecast

Rivian shares jumped over 14% after hours Thursday as the company forecast a 53% rise in 2026 deliveries, driven by its new R2 SUV priced around $45,000. Fourth-quarter deliveries fell to 9,745 and revenue dropped to $1.286 billion. Rivian expects 62,000 to 67,000 deliveries in 2026 and an adjusted EBITDA loss up to $2.1 billion. Shares closed down 5.2% at $14.00 in regular trading.
SLB stock slips despite Indonesia contract win as oil slides — what to watch next

SLB stock slips despite Indonesia contract win as oil slides — what to watch next

SLB shares closed down 1.8% at $50.64 Thursday, little changed after hours, as oil prices slid nearly 3% following an IEA demand outlook cut. The company announced new offshore drilling contracts for Mubadala Energy’s Tangkulo gas project in Indonesia, targeting first production before the end of 2028. Trading volume topped 23 million shares, above average. Financial terms were not disclosed.
Rocket Lab stock price drops 5% as space stocks slide; hypersonic test and Feb. 26 earnings loom

Rocket Lab stock price drops 5% as space stocks slide; hypersonic test and Feb. 26 earnings loom

Rocket Lab shares closed down 5.2% at $66.01 Thursday, extending an 8% three-day slide as space stocks fell after AST SpaceMobile’s $1 billion debt deal. The company flagged a late-February hypersonic test for the U.S. Defense Innovation Unit and will report results Feb. 26, with investors awaiting updates on its Neutron rocket schedule.
Krafton’s next bet after PUBG: humanoid robots, AI — and a 1 trillion won return plan

Krafton’s next bet after PUBG: humanoid robots, AI — and a 1 trillion won return plan

Krafton posted record 2025 revenue of 3.33 trillion won, up 22.8%, but net profit dropped 43.7% to 733.7 billion won. The PUBG maker announced its first cash dividend and a three-year, 1 trillion won shareholder return plan. Krafton is exploring “physical AI” for possible use in humanoid robotics, using in-game data as training material. The company is developing 15 new games and upgrading PUBG to Unreal Engine 5.
Kraken’s 3% Deposit Match Is Live: How the February Promo Pays Up to $30,000 by March 9

Kraken’s 3% Deposit Match Is Live: How the February Promo Pays Up to $30,000 by March 9

Kraken is offering a 3% match on new cash or crypto deposits through March 9, 2026, with a $30,000 cap per account and an 18-month hold requirement. The promotion excludes the UK and Australia. Users must enroll and enable Auto Earn in the Kraken app to qualify. Rewards are paid in USDG or USDC and can be clawed back if net deposits drop below the qualifying level during the hold period.
12 February 2026
Roku stock jumps on upbeat 2026 revenue forecast as ads rebound and subscriptions hit records

Roku stock jumps on upbeat 2026 revenue forecast as ads rebound and subscriptions hit records

Roku forecast 2026 revenue of $5.50 billion, above Wall Street estimates, sending shares up 8% after hours. The company projected 18% growth in 2026 platform revenue to $4.89 billion and guided to $325 million net income. Q4 revenue rose 16% to $1.39 billion, with net income at $80.5 million. Roku reported its largest-ever quarter for Premium Subscriptions net additions.
12 February 2026
Kyndryl’s ‘policy-as-code’ guardrails target runaway AI agents as governance lags

Kyndryl’s ‘policy-as-code’ guardrails target runaway AI agents as governance lags

Kyndryl on Wednesday launched “policy-as-code” controls to enforce business rules on autonomous AI agents in regulated sectors. The company said its system blocks unauthorized actions and logs agent activity for compliance. PYMNTS and CIO.com highlighted rising concerns over accountability and called for stricter management as AI agents take on decision-making roles.
Coinbase CEO Armstrong’s fortune shrinks as COIN posts quarterly loss and filings show $500m stock sales

Coinbase CEO Armstrong’s fortune shrinks as COIN posts quarterly loss and filings show $500m stock sales

Coinbase reported a fourth-quarter loss as trading volumes dropped, with transaction revenue falling to $982.7 million from $1.56 billion a year earlier. CEO Brian Armstrong sold over $500 million in stock since April 2025, according to filings, and his wealth has dropped by more than $10 billion, removing him from Bloomberg’s top-500 rich list.
HCA Healthcare stock stays firm after-hours after a sharp run — here’s what traders watch next

HCA Healthcare stock stays firm after-hours after a sharp run — here’s what traders watch next

HCA Healthcare shares rose 0.7% to $535.22 in after-hours trading Thursday after hitting a high of $552.85 earlier in the day. The move follows a 5.86% jump Wednesday to a record close after HCA’s 2026 profit outlook topped estimates and the company announced a $10 billion buyback. A shareholder filed to sell 8,020 shares worth about $4.1 million. Investors await Friday’s U.S. CPI report.
12 February 2026
Analog Devices stock retreats from 52-week high despite Barclays upgrade ahead of earnings

Analog Devices stock retreats from 52-week high despite Barclays upgrade ahead of earnings

Analog Devices shares fell 1.7% to $331.38 Thursday, despite a Barclays upgrade and price target hike to $375. The stock had hit a 52-week high Wednesday. Traders are watching next week’s earnings and Friday’s U.S. CPI report for signals on demand and industrial orders. Broader tech stocks also dropped after Cisco’s results and ahead of inflation data.

Stock Market Today

  • Sea Limited (NYSE:SE) Valuation Under Scrutiny After 46% One-Year Share Decline
    May 20, 2026, 10:05 AM EDT. Sea Limited (NYSE:SE), active across e-commerce, digital financial services, and digital entertainment in Southeast Asia and Latin America, has seen its stock fall by 46.26% over the past year. Despite recent share price weakness, some analysts argue the stock trades 36.6% below a $137.64 fair value estimate, buoyed by strong revenue growth from Shopee, Monee, and Garena platforms. Key drivers include accelerating mobile internet penetration, youth digital literacy, and shifts toward cashless payments supporting loan book expansion and improved monetization. Market watchers debate whether this dip offers a buying opportunity or reflects tempered growth prospects, especially as Shopee faces competitive pressures. Investors should weigh Sea's potential for earnings growth against market realities and execution risks.

Latest articles

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

Vida CEO Steps In as $15 Million AI IPO Hits Reality Check

20 May 2026
Vida Global Inc. raised $15 million in its May 18 IPO, selling 3.75 million shares at $4 each, but the stock closed at $2.29 on Tuesday. CEO Lyle Pratt bought 312,900 shares for about $1.19 million, according to a Form 4 filing. Vida reported 2025 revenue of $551,383 and a net loss of $2.9 million. The company’s shares trade on NYSE American and NYSE Texas under the symbol VIDA.
TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

TJX Shares Rise Premarket As T.J. Maxx Parent Raises Outlook

20 May 2026
TJX raised its fiscal 2027 sales, earnings, and buyback targets after first-quarter comparable sales rose 6% and net income hit $1.3 billion. Shares climbed 3.6% in premarket trading. The company cited higher fuel costs as a drag on its full-year forecast. Marmaxx, HomeGoods, and TJX Canada all posted strong sales growth.
ImmunityBio in the Spotlight with Patents and BCG Deal Ahead of the Open

ImmunityBio Faces FDA Decision on Bladder-Cancer Application, Risk Remains

20 May 2026
The FDA accepted ImmunityBio’s application to expand Anktiva’s use with BCG in papillary-only, BCG-unresponsive non-muscle invasive bladder cancer, setting a Jan. 6, 2027 decision date. ImmunityBio reported $44.2 million in first-quarter net product revenue and held $380.9 million in cash and equivalents. Shares last traded at $7.76, down 2.8%. The filing is supported by data from 80 patients in a Phase 2/3 trial.
Go toTop